Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 9Not yet recruiting 3Terminated 2Recruiting 2Withdrawn 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Stroke 1Ischemic Attack, Transient 1Cardiovascular Diseases 1Breast Neoplasms 1Atherosclerosis 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER × Rosuvastatin Calcium × Clear all
NCT02114697 2018-09-11

Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging

Emory University

Phase 4 Terminated
9 enrolled 6 charts

Cardiovascular Diseases, Ischemic Attack, Transient, Stroke, Atherosclerosis

NCT01051401 2018-08-01

Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer

Wake Forest University Health Sciences

Phase 1 Terminated
5 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡